Account Bag 0

PRODUCT PROFILE

ADINA TB-500 product vial
ADINA TB-500 product vial

TB-500

£32.99

TB-500 is an experimental peptide linked to part of the natural protein thymosin beta-4. Researchers study cell movement, early tissue repair and wound-related processes. Products sold under this name can vary, so the exact sequence and batch identity matter.

Why it is distinct

TB-500 is discussed as a fragment-like repair material, while thymosin beta-4 is the full natural protein and BPC-157 is studied through different gastric and vascular pathways.

  • Evidence stagePreclinical
  • AvailabilityAvailable · 30 in stock
  • Batch recordPublished after verification
  • DispatchConfirmed at checkout

30 in stock

SKU: ADINA-REC-TB-500-10MG Category:

PRODUCT INFORMATION

Clear first. Detailed when needed.

What this material is+

TB-500 is an experimental peptide linked to part of the natural protein thymosin beta-4. Researchers study cell movement, early tissue repair and wound-related processes. Products sold under this name can vary, so the exact sequence and batch identity matter.

Research focus+

Research mainly looks at actin, the internal structure cells use to move and change shape, and how this may relate to wound repair and new blood-vessel growth.

How the mechanism differs+

Preclinical work links it with actin dynamics, cell migration and early repair signalling. Commercial TB-500 identity can vary between suppliers.

Evidence and limitations+

Evidence is mostly preclinical, and reliable controlled human evidence for marketed TB-500 products is lacking.

Testing and batch documentation+

No live certificate is shown for this staging item. ADINA will only publish a batch document after the product identifier, test method and result have been checked.

RESEARCH PROFILE

Understand the distinction.

Molecular role

A synthetic peptide associated with the actin-binding region of thymosin beta-4.

Research focus

Research mainly looks at actin, the internal structure cells use to move and change shape, and how this may relate to wound repair and new blood-vessel growth.

How it works

Preclinical work links it with actin dynamics, cell migration and early repair signalling. Commercial TB-500 identity can vary between suppliers.

Key differentiator

TB-500 is discussed as a fragment-like repair material, while thymosin beta-4 is the full natural protein and BPC-157 is studied through different gastric and vascular pathways.

Evidence context

Evidence is mostly preclinical, and reliable controlled human evidence for marketed TB-500 products is lacking.

Educational research context only. This information is not dosage, administration or personal-use guidance.

CONTINUE EXPLORING

Related research perspectives.

Selected for useful comparison across neighbouring or contrasting research areas—not as combined-use guidance.